Results 51 to 60 of about 17,459 (201)

the course of a invasive meningococcal disease in a patient of military age from specific prophylaxis (clinical case)

open access: yesЖурнал инфектологии, 2020
Meningococcal infection is an acute infectious disease caused by Neisseria meningitidis, characterized by a polymorphism of clinical manifestations from meningococcus carriage to invasive forms.
V. V. Sharabkhanov   +12 more
doaj   +1 more source

A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control

open access: yesMicroorganisms, 2021
Neisseria meningitidis, carried in the human nasopharynx asymptomatically by ~10% of the population, remains a leading cause of meningitis and rapidly fatal sepsis, usually in otherwise healthy individuals.
Yih-Ling Tzeng, David S. Stephens
doaj   +1 more source

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia [PDF]

open access: yes, 1998
A survey for antibodies to a recombinant small viral capsid antigen (sVCA) of human herpesvirus type 8 (HHV‐8) was conducted in Sardinia, one of the world's highest incidence areas for classic Kaposi's sarcoma (KS). Prevalence of antibodies to HHV‐8 sVCA
Angeloni, Antonio   +11 more
core   +1 more source

Invasive Meningococcal Disease and Vaccines

open access: yesTuberculin Skin Test in Children, 2013
Meningokok infeksiyonlari butun dunyada onemli saglik sorunlari arasinda yer almaya devam etmektedir. Invaziv Meningokok hastaligi cocukluk caginda % 10 oraninda olumcul olabilmektedir. Vakalarin % 75’inden serogrup A, C, Y ve W135 sorumludur. IMH asilama ile onlenebilir bir hastaliktir.
HANÇERLİ TÖRÜN, Selda, SALMAN, Nuran
openaire   +2 more sources

Profile of Serogroup Y Meningococcal Infections in Canada: Implications for Vaccine Selection

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2009
Canada is a leader in establishing routine infant immunization programs against meningococcal C disease. Currently, all provinces have routine programs to provide meningococcal C conjugate vaccines to infants and children.
Nicole Le Saux   +6 more
doaj   +1 more source

What is the evidence for giving chemoprophylaxis to children or students attending the same preschool, school or college as a case of meningococcal disease? [PDF]

open access: yes, 2011
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings.
Ackerman   +30 more
core   +2 more sources

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence [version 2; peer review: 2 approved]

open access: yesWellcome Open Research, 2019
Carriage of Neisseria meningitidis, the meningococcus, is a prerequisite for invasive meningococcal disease (IMD), a potentially devastating infection that disproportionately afflicts infants and children.
Holly B. Bratcher   +15 more
doaj   +1 more source

Insights on Population Structure and Within-Host Genetic Changes among Meningococcal Carriage Isolates from U.S. Universities

open access: yesmSphere, 2020
In 2015 and 2016, meningococcal carriage evaluations were conducted at two universities in the United States following mass vaccination campaigns in response to Neisseria meningitidis serogroup B (NmB) disease outbreaks.
Sandeep J. Joseph   +15 more
doaj   +1 more source

Meningococcemia in a vaccinated child receiving eculizumab and review of the literature

open access: yesThe Turkish Journal of Pediatrics, 2023
Background. Atypical hemolytic uremic syndrome (aHUS) is a rare and severe disease characterized by uncontrolled activation and dysregulation of the alternative complement pathway and development of thrombotic microangiopathy. Eculizumab, which is
Diana Üçkardeş   +5 more
doaj   +1 more source

Bacterial outer membrane vesicles and vaccine applications [PDF]

open access: yes, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Acevedo, Reinaldo   +10 more
core   +2 more sources

Home - About - Disclaimer - Privacy